Patents/Assignees

Synaptogenix, Inc.

3 patents in portfolio

US12016837utility2024
Halogenated Esters of Cyclopropanated Unsaturated Fatty Acids for Use in the Treatment of Neurodegenerative Diseases
0 cites
US11826345utility2023
Dosing Regimens of PKC Activators
0 cites
US11820745utility2023
Pkc-activating Compounds for the Treatment of Neurodegenerative Diseases
0 cites